The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFG.L Regulatory News (PFG)

  • There is currently no data for PFG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI) - PROVIDENT FINANCIAL PLC

15 May 2019 11:20

FORM 8.5 (EPT/NON-RI)

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
(b) Name of offeror/offeree in relation to whose PROVIDENT FINANCIAL PLC
relevant securities this form relates:
(c) Name of the party to the offer with which exempt PROVIDENT FINANCIAL PLC
principal trader is connected
(d) Date position held/dealing undertaken: 14 May 2019
(e) In addition to the company in 1(b) above, is the exempt principal NO:
trader making disclosures in respect of any other party to the offer?

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 20 8/11p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 115,726 0.05% 360,530 0.14%
(2) Cash-settled derivatives:
233,329 0.09% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 349,055 0.14% 360,530 0.14%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
20 8/11p ordinary Purchase 16,405 4.8149 GBP 4.8041 GBP
20 8/11p ordinary Sale 9,906 4.8240 GBP 4.793 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
20 8/11p ordinary SWAP Long 200 4.7934 GBP
20 8/11p ordinary SWAP Long 2,092 4.7985 GBP
20 8/11p ordinary SWAP Long 2,324 4.8120 GBP
20 8/11p ordinary CFD Long 2,565 4.8053 GBP
20 8/11p ordinary SWAP Short 13,680 4.8126 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 15 May 2019
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190515005416/en/

Copyright Business Wire 2019

Date   Source Headline
2nd Jun 20219:36 amRNSHolding(s) in Company
28th May 20214:30 pmRNSTotal Voting Rights
24th May 20214:42 pmRNSHolding(s) in Company
12th May 20214:00 pmRNSDirector/PDMR Shareholding
10th May 20213:20 pmRNSHolding(s) in Company
10th May 20219:44 amRNSPFG Annual Report and Accounts and AGM Notice
10th May 20217:00 amRNSPFG 2020 Preliminary Results Announcement
4th May 20217:00 amRNSStatement re Operational Review of CCD Update
30th Apr 20214:30 pmRNSTotal Voting Rights
30th Apr 20213:02 pmRNSHolding(s) in Company
29th Apr 20213:21 pmRNSHolding(s) in Company
22nd Apr 20213:49 pmRNSScheme of Arrangement Update
1st Apr 20211:00 pmRNSDirector/PDMR Shareholding
31st Mar 20214:30 pmRNSTotal Voting Rights
31st Mar 202110:35 amRNSHolding(s) in Company
30th Mar 20219:26 amRNSHolding(s) in Company
25th Mar 20211:42 pmRNSHolding(s) in Company
19th Mar 20211:45 pmRNSHolding(s) in Company
19th Mar 20211:40 pmRNSHolding(s) in Company
17th Mar 20214:14 pmRNSHolding(s) in Company
15th Mar 20217:00 amRNSStatement re Trading Update and CCD Scheme
15th Mar 20217:00 amRNSStatement re Notice of Guarantor Changes
4th Mar 20213:04 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSTotal Voting Rights
10th Feb 20212:42 pmRNSHolding(s) in Company
5th Feb 20219:17 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSHolding(s) in Company
1st Feb 20212:32 pmRNSHolding(s) in Company
29th Jan 20214:30 pmRNSTotal Voting Rights
18th Jan 20213:38 pmRNSHolding(s) in Company
15th Jan 20212:41 pmRNSBlock listing Interim Review
15th Jan 202112:57 pmRNSHolding(s) in Company
7th Jan 20217:00 amRNSStatement re Notice of Accession of Guarantor
31st Dec 20201:00 pmRNSTotal Voting Rights
21st Dec 20207:00 amRNSStatement re Notice of Guarantor Changes
17th Dec 20201:35 pmRNSHolding(s) in Company
16th Dec 202011:46 amRNSDirector/PDMR Shareholding
9th Dec 202010:42 amRNSHolding(s) in Company
30th Nov 20204:30 pmRNSTotal Voting Rights
16th Nov 20203:12 pmRNSHolding(s) in Company
9th Nov 20204:30 pmRNSDirector/PDMR Shareholding
9th Nov 20201:54 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSThird Quarter Trading Update
3rd Nov 20203:30 pmRNSHolding(s) in Company
3rd Nov 202011:53 amRNSResult of General Meeting
30th Oct 20204:30 pmRNSTotal Voting Rights
26th Oct 202012:13 pmRNSHolding(s) in Company
22nd Oct 20205:35 pmRNSHolding(s) in Company
19th Oct 20202:29 pmRNSHolding(s) in Company
16th Oct 20202:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.